Literature DB >> 11391255

Long-term results of the first 500 cases of acoustic neuroma surgery.

R J Wiet1, B Mamikoglu, L Odom, D L Hoistad.   

Abstract

OBJECTIVE: This retrospective study focuses on 2 outcome results after surgical intervention for acoustic neuroma: (1) facial nerve status, and (2) hearing preservation. STUDY
DESIGN: A total of 484 patients with an acoustic neuroma.
RESULTS: Postoperative facial nerve outcomes were significantly different (P < 0.001) according to the size of the tumors. Tumor size had even more influence on the immediate postoperative results. In addition, statistical significance (P < 0.05) was demonstrated in comparing facial nerve outcomes with the surgeon's surgical experience. We also noted that as the patient's age increases, the likelihood for facial dysfunction may increase for all postoperative intervals. The overall success rate of retaining useful hearing was 27% (26 of 95). Class A hearing was retained in 66% (10 of 15) of cases operated on through middle fossa approach in the last 5 years.
CONCLUSION: This study demonstrates that tumor size and surgeon's experience are the most significant factors influencing the facial nerve status and hearing outcome after removal of acoustic neuroma.

Entities:  

Mesh:

Year:  2001        PMID: 11391255     DOI: 10.1177/019459980112400609

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  16 in total

1.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

2.  Hearing preservation surgery for vestibular schwannomas via the retrosigmoid transmeatal approach: surgical tips.

Authors:  Masahiko Wanibuchi; Takanori Fukushima; Allan H Friedman; Kentaro Watanabe; Yukinori Akiyama; Takeshi Mikami; Satoshi Iihoshi; Tomohiro Murakami; Toshiya Sugino; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2014-04-22       Impact factor: 3.042

3.  Setting the standard--UK neurosurgical acoustic neuroma practice.

Authors:  J R Goodden; R Tranter; C Hardwidge
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

4.  Validation of the facial dysfunction domain of the Penn Acoustic Neuroma Quality-of-Life (PANQOL) Scale.

Authors:  Wouter L Lodder; Guleed H Adan; Chung S Chean; Tristram H Lesser; Samuel C Leong
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-08       Impact factor: 2.503

5.  Cerebellopontine angle lesions in children.

Authors:  Graciela Zúccaro; Fidel Sosa
Journal:  Childs Nerv Syst       Date:  2006-10-28       Impact factor: 1.475

6.  What is the best tumor size to achieve optimal functional results in vestibular schwannoma surgery?

Authors:  Mislav Gjuric; Milan Rudic
Journal:  Skull Base       Date:  2008-09

7.  What really decides the facial function of vestibular schwannoma surgery?

Authors:  Jin Kim; In Seok Moon; Jun Hui Jeong; Hyung Rok Lee; Won Sang Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-12-15       Impact factor: 3.372

8.  Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression.

Authors:  Ali Harati; Kai-Michael Scheufler; Rolf Schultheiss; Albaraa Tonkal; Kamran Harati; Paul Oni; Thomas Deitmer
Journal:  Surg Neurol Int       Date:  2017-04-05

9.  Surgical treatment of sporadic vestibular schwannoma in a series of 1006 patients.

Authors:  Z Zhang; Y Nguyen; D De Seta; F Y Russo; A Rey; M Kalamarides; O Sterkers; D Bernardeschi
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-10       Impact factor: 2.124

10.  Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Marc Levivier
Journal:  Acta Neurochir (Wien)       Date:  2017-05-17       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.